Trademark: KYVERNA TAMING AUTOIMMUNITY 2190414
Word
KYVERNA TAMING AUTOIMMUNITY
Device Descrption:
CROSS WITH RAYS
ID
2190414
Trademark Type
Figurative
Status
Registered: Registered/protected
Application Date
30 June 2021
Registration Date
30 June 2021
Renewal Date
30 June 2031
Owner(s)
Service
Pizzeys Patent and Trade Mark Attorneys Pty Ltd
Goods and Services:
Class 5:
Pharmaceuticals; pharmaceutical preparations; pharmaceutical therapeutic agents for medical use; therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products for the treatment of autoimmune disease; cells for medical use; living cells for medical use; cell therapy products, namely, genetically engineered immune cells for the treatment of autoimmune disease; antibodies; antibody receptors; antigens; antigen receptors; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, namely, diagnostic reagents for medical purposes; control reagents for medical laboratory purposes; control reagents for clinical medical purposes.
Pharmaceuticals; pharmaceutical preparations; pharmaceutical therapeutic agents for medical use; therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products for the treatment of autoimmune disease; cells for medical use; living cells for medical use; cell therapy products, namely, genetically engineered immune cells for the treatment of autoimmune disease; antibodies; antibody receptors; antigens; antigen receptors; diagnostic agents, preparations and substances for medical purposes; pharmaceutical products, namely, diagnostic reagents for medical purposes; control reagents for medical laboratory purposes; control reagents for clinical medical purposes.
Class 42:
Scientific and technological services and research and design relating thereto; industrial analysis and research services; research, development, testing and evaluation of pharmaceuticals, pharmaceutical preparations and pharmaceutical therapeutic agents; research, development, testing and evaluation of medical preparations, cells for medical use, antibodies, antibody receptors, antigens and antigen receptors; medical research and development; research, development, testing and evaluation of diagnostic agents, preparations and substances for medical purposes; medical and scientific research and development in the field of diagnosis and treatment of autoimmune disease; information, advice and consultancy regarding the aforementioned services.
Scientific and technological services and research and design relating thereto; industrial analysis and research services; research, development, testing and evaluation of pharmaceuticals, pharmaceutical preparations and pharmaceutical therapeutic agents; research, development, testing and evaluation of medical preparations, cells for medical use, antibodies, antibody receptors, antigens and antigen receptors; medical research and development; research, development, testing and evaluation of diagnostic agents, preparations and substances for medical purposes; medical and scientific research and development in the field of diagnosis and treatment of autoimmune disease; information, advice and consultancy regarding the aforementioned services.
Class 44:
Medical services; medical information services; medical testing services; medical diagnostic testing services; medical treatment services; medical services, namely, cell based therapies; medical services for the diagnosis and treatment of autoimmune disease; medical services, namely, cell based therapies; information, advice and consultancy regarding the aforementioned services.
Medical services; medical information services; medical testing services; medical diagnostic testing services; medical treatment services; medical services, namely, cell based therapies; medical services for the diagnosis and treatment of autoimmune disease; medical services, namely, cell based therapies; information, advice and consultancy regarding the aforementioned services.